{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:49:32Z","timestamp":1757576972626,"version":"3.41.2"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The role of the Wnt pathway in bone and its targets in skeletal disease has garnered interest, but the field lacks a systematic analysis of research. This paper presents a bibliometric study of publications related to the Wnt signaling pathway in bone to describe the current state of study and predict future outlooks.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> All relevant articles and reviews from 1993 to 2022 were collected from the Web of Science Core Collection (WoSCC). Bibliometric analysis and visualization were performed using CiteSpace 6.1 R3, VOSviewer 1.6.15, and the Online Analysis Platform of Literature Metrology (<jats:ext-link>http:\/\/bibliometric.com\/<\/jats:ext-link>).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 7,184 papers were retrieved, authored by 28,443 researchers from 89 countries\/regions and published in 261 academic journals. The annual publication numbers peaked in 2021. China and United States are the leading countries, with the University of California and Harvard University as the most active institutions. Wang, Yang is the most prolific author. Bone has the most published research, while Proceedings of the National Academy of Sciences of the United States is the most cited journal on average. The main keywords include expression, Wnt, osteoporosis, bone, and osteogenic differentiation. Current and developing research hotspots focus on bone mass, sclerostin antibody, multiple myeloma, and cartilage development.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This paper provides new insights for researchers to delve into the mechanisms of Wnt and bone related diseases and translate into clinical studies. It reveals the development and future research trends in Wnt and skeletal-related studies.<\/jats:p>","DOI":"10.3389\/fphys.2023.1279423","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T18:28:33Z","timestamp":1700159313000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Wnt pathway in bone: knowledge structure and hot spots from 1993 to 2022"],"prefix":"10.3389","volume":"14","author":[{"given":"Tun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jidong","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1002\/jcp.26111","article-title":"Gsk-3\u03b2 inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation","volume":"233","author":"Amirhosseini","year":"2018","journal-title":"J. Cell Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41574-018-0087-0","article-title":"Clinical advantages and disadvantages of anabolic bone therapies targeting the wnt pathway","volume":"14","author":"Appelman-Dijkstra","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"Bibliometrix: an R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J. Inf."},{"key":"B4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.molmed.2005.01.004","article-title":"Genetic disorders of the lrp5\u2013wnt signalling pathway affecting the skeleton","volume":"11","author":"Audrey Koay","year":"2005","journal-title":"Trends Mol. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1359\/jbmr.2003.18.6.960","article-title":"High bone mass in mice expressing a mutant Lrp5 gene","volume":"18","author":"Babij","year":"2003","journal-title":"J. Bone Mineral Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1359\/jbmr.070211","article-title":"Novel Lrp5 missense mutation in a patient with a high bone mass phenotype results in decreased dkk1-mediated inhibition of wnt signaling","volume":"22","author":"Balemans","year":"2007","journal-title":"J. Bone Mineral Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"Wnt signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa013444","article-title":"High bone density due to a mutation in ldl-receptor\u2013related protein 5","volume":"346","author":"Boyden","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"30938","DOI":"10.1074\/jbc.M702391200","article-title":"Noncanonical wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of P38 mapk","volume":"282","author":"Chang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"Citespace ii: detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2006","journal-title":"J. Am. Soc. Inf. Sci. Technol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"884030","DOI":"10.3389\/fimmu.2022.884030","article-title":"Global trends in research of lipid metabolism in T lymphocytes from 1985 to 2022: a bibliometric analysis","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/jbmr.3463","article-title":"Postnatal skeletal deletion of dickkopf-1 increases bone formation and bone volume in male and female mice, despite increased sclerostin expression","volume":"33","author":"Colditz","year":"2018","journal-title":"J. Bone Mineral Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/art.27231","article-title":"Evidence that dkk-1 is dysfunctional in ankylosing spondylitis","volume":"62","author":"Daoussis","year":"2010","journal-title":"Arthritis & Rheumatism"},{"key":"B15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle","year":"2017","journal-title":"Bone"},{"key":"B16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/annrheumdis-2012-202184","article-title":"Genetic studies on components of the wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis","volume":"72","author":"Diederik","year":"2013","journal-title":"Ann. Rheumatic Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"11505","DOI":"10.1038\/ncomms11505","article-title":"A bispecific antibody targeting sclerostin and dkk-1 promotes bone mass accrual and fracture repair","volume":"7","author":"Florio","year":"2016","journal-title":"Nat. Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.3390\/cancers14174173","article-title":"Ck1\u03b1\/Runx2 Axis in the bone marrow microenvironment: a novel therapeutic target in multiple myeloma","volume":"14","author":"Fregnani","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41375-019-0486-9","article-title":"The wnt receptor Ror2 drives the interaction of multiple myeloma cells with the microenvironment through akt activation","volume":"34","author":"Frenquelli","year":"2020","journal-title":"Leukemia"},{"key":"B20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jpha.2020.08.005","article-title":"Liquid chromatography-mass spectrometry method for the quantification of an anti-sclerostin monoclonal antibody in cynomolgus monkey serum","volume":"11","author":"Gao","year":"2021","journal-title":"J. Pharm. Anal."},{"key":"B21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/annrheumdis-2011-200216","article-title":"High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis","volume":"71","author":"Gisela Ruiz","year":"2012","journal-title":"Ann. Rheumatic Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/jbmr.3143","article-title":"Bps804 anti-sclerostin antibody in adults with moderate osteogenesis imperfecta: results of a randomized phase 2a trial","volume":"32","author":"Glorieux","year":"2017","journal-title":"J. Bone Mineral Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"Ldl receptor-related protein 5 (Lrp5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fcell.2018.00170","article-title":"Wnt pathway in bone repair and regeneration - what do we know so far","volume":"6","author":"Houschyar","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.joca.2017.05.018","article-title":"Wnt5a induces catabolic signaling and matrix metalloproteinase production in human articular chondrocytes","volume":"25","author":"Huang","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"B26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s13287-022-03205-3","article-title":"Regulatory of mirnas in tri-lineage differentiation of C3h10t1\/2","volume":"13","author":"Huang","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/bjh.13056","article-title":"A phase ib multicentre dose-determination study of Bhq880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events","volume":"167","author":"Iyer","year":"2014","journal-title":"Br. J. Haematol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"7362","DOI":"10.1038\/ncomms8362","article-title":"Nell-1 in the treatment of osteoporotic bone loss","volume":"6","author":"James","year":"2015","journal-title":"Nat. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.03.031","article-title":"Evolving functions of dickkopf-1 in cancer and immunity","volume":"482","author":"Jaschke","year":"2020","journal-title":"Cancer Lett."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e7073","DOI":"10.7717\/peerj.7073","article-title":"Wnt signaling in liver disease: emerging trends from a bibliometric perspective","volume":"7","author":"Jiang","year":"2019","journal-title":"PeerJ"},{"key":"B31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tem.2012.10.003","article-title":"Lrp5 and Lrp6 in development and disease","volume":"24","author":"Joiner","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00018-016-2425-5","article-title":"Wnt signaling and cellular metabolism in osteoblasts","volume":"74","author":"Karner","year":"2017","journal-title":"Cell Mol. Life Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1083\/jcb.200201089","article-title":"Cbfa1-Independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a wnt coreceptor","volume":"157","author":"Kato","year":"2002","journal-title":"J. Cell Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00018-018-2981-y","article-title":"Coupling factors involved in preserving bone balance","volume":"76","author":"Kim","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1056\/NEJMoa1509342","article-title":"Cortical-bone fragility--insights from Sfrp4 deficiency in pyle's disease","volume":"374","author":"Kiper","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1002\/jbmr.472","article-title":"Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury","volume":"26","author":"Li","year":"2011","journal-title":"J. Bone Mineral Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J. Bone Mineral Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1086\/338450","article-title":"A mutation in the ldl receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait","volume":"70","author":"Little","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrrheum.2013.25","article-title":"To wnt or not to wnt: the bone and joint health dilemma","volume":"9","author":"Lories","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1002\/art.23137","article-title":"Articular cartilage and biomechanical properties of the long bones in frzb-knockout mice","volume":"56","author":"Lories","year":"2007","journal-title":"Arthritis & Rheumatism"},{"key":"B41","doi-asserted-by":"publisher","first-page":"9757","DOI":"10.1073\/pnas.0403456101","article-title":"Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females","volume":"101","author":"Loughlin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B42","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.3390\/ijms20225525","article-title":"The regulation of bone metabolism and disorders by wnt signaling","volume":"20","author":"Maeda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.2653","article-title":"Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis","volume":"18","author":"Maeda","year":"2012","journal-title":"Nat. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/jbmr.2092","article-title":"Single- and multiple-dose randomized studies of Blosozumab, a monoclonal antibody against sclerostin, in healthy postmenopausal women","volume":"29","author":"McColm","year":"2014","journal-title":"J. Bone Mineral Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm.3654","article-title":"Osteoblast-derived Wnt16 represses osteoclastogenesis and prevents cortical bone fragility fractures","volume":"20","author":"Mov\u00e9rare-Skrtic","year":"2014","journal-title":"Nat. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/annrheumdis-2015-208577","article-title":"Wnt16 antagonises excessive canonical wnt activation and protects cartilage in osteoarthritis","volume":"76","author":"Nalesso","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/bonekey.2012.183","article-title":"Bone cell communication factors and semaphorins","volume":"1","author":"Negishi-Koga","year":"2012","journal-title":"Bonekey Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.3390\/ijms21207623","article-title":"Molecular mechanisms and emerging therapeutics for osteoporosis","volume":"21","author":"Noh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u0392-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of amg 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J. Bone Mineral Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainresbull.2019.12.004","article-title":"Analysis of knowledge bases and research focuses of cerebral ischemia-reperfusion from the perspective of mapping knowledge domain","volume":"156","author":"Qin","year":"2020","journal-title":"Brain Res. Bull."},{"key":"B52","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev-physiol-021119-034332","article-title":"The osteocyte: new insights","volume":"82","author":"Robling","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1152\/physiol.00061.2014","article-title":"Physiological bone remodeling: systemic regulation and growth factor involvement","volume":"31","author":"Siddiqui","year":"2016","journal-title":"Physiol. (Bethesda)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-018-0615-3","article-title":"Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential","volume":"11","author":"Spaan","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.berh.2018.03.004","article-title":"Wnt signaling as target for the treatment of osteoarthritis","volume":"31","author":"Stampella","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the wnt-signaling antagonist Dkk1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41375-019-0404-1","article-title":"Aberrant wnt signaling in multiple myeloma: molecular mechanisms and targeting options","volume":"33","author":"van Andel","year":"2019","journal-title":"Leukemia"},{"key":"B59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1359\/jbmr.061002","article-title":"Wnt but not bmp signaling is involved in the inhibitory action of sclerostin on bmp-stimulated bone formation","volume":"22","author":"van Bezooijen","year":"2007","journal-title":"J. Bone Mineral Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.ajpath.2015.03.013","article-title":"Induction of canonical wnt signaling by synovial overexpression of selected wnts leads to protease activity and early osteoarthritis-like cartilage damage","volume":"185","author":"van den Bosch","year":"2015","journal-title":"Am. J. Pathology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: vosviewer, a computer Program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B62","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1086\/368277","article-title":"Six novel missense mutations in the ldl receptor-related protein 5 (Lrp5) gene in different conditions with an increased bone density","volume":"72","author":"Van Wesenbeeck","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"B63","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biocel.2015.09.008","article-title":"Multi-lineage differentiation of mesenchymal stem cells \u2013 to wnt, or not wnt","volume":"68","author":"Visweswaran","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12964-019-0411-x","article-title":"Wnt signaling: a promising target for osteoarthritis therapy","volume":"17","author":"Wang","year":"2019","journal-title":"Cell Commun. Signal"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.21037\/atm-21-174","article-title":"A bibliometric analysis of wnt signaling pathway: from the top-100 cited articles to emerging trends","volume":"9","author":"Xu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","article-title":"Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum","volume":"135","author":"Yadav","year":"2008","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1096\/fj.201901550R","article-title":"Amyloid \u0392 peptide promotes bone formation by regulating wnt\/\u0392-catenin signaling and the opg\/rankl\/rank system","volume":"34","author":"Yang","year":"2020","journal-title":"FASEB J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/art.41315","article-title":"Lorecivivint, a novel intraarticular cdc-like kinase 2 and dual-specificity tyrosine phosphorylation-regulated kinase 1a inhibitor and wnt pathway modulator for the treatment of knee osteoarthritis: a phase ii randomized trial","volume":"72","author":"Yazici","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.apsb.2022.01.012","article-title":"Drug discovery of sclerostin inhibitors","volume":"12","author":"Yu","year":"","journal-title":"Acta Pharm. Sin. B"},{"key":"B70","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1038\/s41467-022-31997-8","article-title":"Targeting Loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation","volume":"13","author":"Yu","year":"","journal-title":"Nat. Commun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e0185236","DOI":"10.1371\/journal.pone.0185236","article-title":"Sirt1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis","volume":"12","author":"Zainabadi","year":"2017","journal-title":"PLoS One"},{"key":"B72","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.blre.2013.08.002","article-title":"Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic intervention","volume":"27","author":"Zhou","year":"2013","journal-title":"Blood Rev."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1279423\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T18:28:35Z","timestamp":1700159315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1279423\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":72,"alternative-id":["10.3389\/fphys.2023.1279423"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2023.1279423","relation":{},"ISSN":["1664-042X"],"issn-type":[{"type":"electronic","value":"1664-042X"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"article-number":"1279423"}}